Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study

Crit Care. 2020 Jul 14;24(1):429. doi: 10.1186/s13054-020-03154-4.
No abstract available

Keywords: Adjuvant therapies; Atorvastatin; COVID-19; Critical care; Emerging disease; Immunomodulators; Statins.

Publication types

  • Letter

MeSH terms

  • Aged
  • Atorvastatin / therapeutic use*
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / mortality
  • Female
  • Hospital Mortality
  • Humans
  • Intensive Care Units
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / mortality
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Atorvastatin